Analyst Ratings for SciClone Pharmaceuticals (SCLN)
SCLN Rating Summary
SCLN Price Target Summary
- Highest: $12.00 (Aegis Capital)
- Lowest: $8.25 (BWS Financial)
- Average: $10.13
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.13 (+108.3%)
Avg. $ Target:
$10.13 (+108.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/18/2012 | BWS Financial | Upgrade | Buy (Hold) |
8.25 (N/A) |
4.69 | 4.86 | 3.62% | Details |
| 8/13/2012 | Cowen | Downgrade | Neutral (Outperform) |
N/A (N/A) |
5.70 | 4.86 | -14.74% | Details |
| 7/25/2012 | Aegis Capital | New Coverage | Buy (N/A) |
12.00 (N/A) |
5.74 | 4.86 | -15.33% | Details |
